Granisetron [granisetron]
- Terms
-
1-methyl-N-(endo-9-methyl-9-azabicyklo(3.3.1)non-3-yl)-1H-indazol-3-karboxamid
1H-indazol-3-karboxamid, 1-methyl-N-(9-methyl-9-azabicyklo(3.3.1)non-3-yl
BRL-43694
BRL-43694A
granisetron-hydrochlorid
Kytril
-
1-methyl-N-(endo-9-methyl-9-azabicyclo(3.3.1)non-3-yl)-1H-indazole-3-carboxamide
1H-Indazole-3-carboxamide, 1-methyl-N-(9-methyl-9-azabicyclo(3.3.1)non-3-yl
1H-Indazole-3-carboxamide, 1-methyl-N-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-, endo-
BRL-43694
BRL-43694A
Granisetron Hydrochloride
Granisetron Monohydrochloride
Kytril
A serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic for cancer chemotherapy patients.
- DUI
- D017829 MeSH Browser
- CUI
- M0026935
- Previous indexing
- Indazoles (1988-1993)
- History note
- 94; was GRANISETRON (NM) 1988-93
- Online note
- use GRANISETRON (NM) to search GRANISETRON 1988-93
- Public note
- 94; GRANISETRON was indexed under INDAZOLES 1988-93
Allowable subheadings
- AD
- administration & dosage 3
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 4
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 5
- TO
- toxicity
- UR
- urine